CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (In millions, except per share data) Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Net Sales $ 1,530.0 $ 1,506.3 $ 2,999.3 $ 2,973.4 Cost of sales 836.1 859.3 1,624.0 1,666.8 Gross Profit 693.9 647.0 1,375.3 1,306.6 Marketing expenses 165.3 157.1 304.7 293.7 Selling, general and administrative expenses 252.2 228.2 503.2 455.9 Income from Operations 276.4 261.7 567.4 557.0 Equity in earnings of affiliates 2.7 2.8 5.0 4.4 Interest income 1.4 9.2 3.9 18.5 Interest expense (24.2 ) (23.5 ) (48.2 ) (46.8 ) Other income (expense), net (0.4 ) 0.3 0.4 (0.5 ) Income before Income Taxes 255.9 250.5 528.5 532.6 Income taxes 53.1 59.5 109.4 121.5 Net Income $ 202.8 $ 191.0 $ 419.1 $ 411.1 Weighted average shares outstanding - Basic 236.7 244.7 236.6 245.2 Weighted average shares outstanding - Diluted 238.2 246.4 238.2 247.2 Net income per share - Basic $ 0.86 $ 0.78 $ 1.77 $ 1.68 Net income per share - Diluted $ 0.85 $ 0.78 $ 1.76 $ 1.66 Cash dividends per share $ 0.31 $ 0.30 $ 0.62 $ 0.59 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (In millions) Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Net Income $ 202.8 $ 191.0 $ 419.1 $ 411.1 Other comprehensive income, net of tax: Foreign exchange translation adjustments 0.0 16.9 (4.5 ) 23.2 Defined benefit plan adjustments gain (loss) 0.0 0.0 (0.4 ) 0.4 Income (loss) from derivative agreements 2.1 (9.2 ) 10.3 (11.1 ) Other comprehensive income 2.1 7.7 5.4 12.5 Comprehensive income $ 204.9 $ 198.7 $ 424.5 $ 423.6 See Notes to Condensed Consolidated Financial Statements (Unaudited). 3 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In millions, except share and per share data) June 30, December 31, 2026 2025 Assets Current Assets Cash and cash equivalents $ 254.8 $ 409.0 Accounts receivable, less allowances of $2.6 and $3.7 596.8 593.4 Inventories 601.9 534.8 Other current assets 68.2 59.8 Total Current Assets 1,521.7 1,597.0 Property, Plant and Equipment, Net 826.5 822.8 Equity Investment in Affiliates 12.1 10.3 Trade Names and Other Intangibles, Net 3,743.1 3,511.5 Goodwill 2,649.9 2,627.5 Other Assets 352.4 343.3 Total Assets $ 9,105.7 $ 8,912.4 Liabilities and Stockholders' Equity Current Liabilities Short-term borrowings $ 49.9 $ 0.0 Accounts payable 775.9 732.4 Accrued expenses and other liabilities 481.9 583.0 Business acquisition and divestiture liabilities 14.6 178.9 Income taxes payable 4.9 3.4 Total Current Liabilities 1,327.2 1,497.7 Long-term Debt 2,206.3 2,205.1 Deferred Income Taxes 894.1 886.9 Deferred and Other Long-term Liabilities 330.3 320.5 Total Liabilities 4,757.9 4,910.2 Commitments and Contingencies Stockholders' Equity Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued 0.0 0.0 Common Stock, $1.00 par value, Authorized 600,000,000 shares and 293,709,982 shares issued as of June 30, 2026 and December 31, 2025 293.7 293.7 Additional paid-in capital 676.9 625.1 Retained earnings 7,040.3 6,768.2 Accumulated other comprehensive loss (14.5 ) (19.9 ) Common stock in treasury, at cost: 56,573,080 shares as of June 30, 2026 and 57,156,105 shares as of December 31, 2025 (3,648.6 ) (3,664.9 ) Total Stockholders' Equity 4,347.8 4,002.2 Total Liabilities and Stockholders' Equity $ 9,105.7 $ 8,912.4 See Notes to Condensed Consolidated Financial Statements (Unaudited). 4 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) (In millions) Six Months Ended June 30, June 30, 2026 2025 Cash Flow From Operating Activities Net Income $ 419.1 $ 411.1 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation expense 43.6 45.1 Amortization expense 83.6 72.4 Deferred income taxes 4.4 (12.8 ) Business exit related impairments 0.0 51.0 Equity in net earnings of affiliates (5.0 ) (4.4 ) Distributions from unconsolidated affiliates 3.2 4.3 Non-cash compensation expense 42.6 30.2 Other 5.1 5.7 Subtotal 596.6 602.6 Change in assets and liabilities: Accounts receivable (5.9 ) 4.3 Inventories (65.4 ) (2.9 ) Other current assets (12.1 ) (0.9 ) Accounts payable 52.5 (13.5 ) Accrued expenses (105.2 ) (149.6 ) Income taxes payable 11.2 (12.9 ) Other operating assets and liabilities, net (10.1 ) (10.6 ) Change in Working Capital (135.0 ) (186.1 ) Net Cash Provided By Operating Activities 461.6 416.5 Cash Flow From Investing Activities Additions to property, plant and equipment (61.8 ) (39.0 ) Acquisition, net of cash acquired (300.0 ) 0.0 Other (0.1 ) (0.6 ) Net Cash Used In Investing Activities (361.9 ) (39.6 ) Cash Flow From Financing Activities Payment of cash dividends (145.8 ) (145.0 ) Purchase of treasury stock 0.0 (300.0 ) Payment of business acquisition liabilities (180.5 ) (5.9 ) Short-term debt borrowings (repayments) 49.9 0.0 Proceeds from stock options exercised 30.8 26.6 Other stock award activity (5.7 ) (2.5 ) Other (0.4 ) 0.0 Net Cash Used In Financing Activities (251.7 ) (426.8 ) Effect of exchange rate changes on cash and cash equivalents (2.2 ) 9.0 Net Change In Cash and Cash Equivalents (154.2 ) (40.9 ) Cash and Cash Equivalents at Beginning of Period 409.0 964.1 Cash and Cash Equivalents at End of Period $ 254.8 $ 923.2 See Notes to Condensed Consolidated Financial Statements (Unaudited). 5 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW-CONTINUED (Unaudited) (In millions) Six Months Ended June 30, June 30, 2026 2025 Cash paid during the period for: Interest (net of amounts capitalized) $ 47.7 $ 46.6 Income taxes $ 92.6 $ 146.7 Supplemental disclosure of non-cash investing activities: Property, plant and equipment expenditures included in Accounts Payable $ 10.2 $ 15.0 See Notes to Condensed Consolidated Financial Statements (Unaudited). 6 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) (In millions) Number of Shares Amounts Common Stock Treasury Stock Common Stock Additional Paid-In Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Treasury Stock Total Stockholders' Equity January 1, 2025 293.7 (47.8 ) $ 293.7 $ 563.1 $ 6,319.7 $ (30.9 ) $ (2,784.8 ) $ 4,360.8 Net income 0.0 0.0 0.0 0.0 220.1 0.0 0.0 220.1 Other comprehensive income 0.0 0.0 0.0 0.0 0.0 4.8 0.0 4.8 Cash dividends 0.0 0.0 0.0 0.0 (72.4 ) 0.0 0.0 (72.4 ) Stock based compensation expense and stock option plan transactions 0.0 0.3 0.0 27.2 (0.2 ) 0.0 10.7 37.7 March 31, 2025 293.7 (47.5 ) $ 293.7 $ 590.3 $ 6,467.2 $ (26.1 ) $ (2,774.1 ) $ 4,551.0 Net income 0.0 0.0 0.0 0.0 191.0 0.0 0.0 191.0 Other comprehensive income 0.0 0.0 0.0 0.0 0.0 7.7 0.0 7.7 Cash dividends 0.0 0.0 0.0 0.0 (72.6 ) 0.0 0.0 (72.6 ) Stock purchases 0.0 (2.8 ) 0.0 (30.0 ) 0.0 0.0 (270.0 ) (300.0 ) Stock based compensation expense and stock option plan transactions 0.0 0.1 0.0 12.2 (0.2 ) 0.0 4.6 16.6 June 30, 2025 293.7 (50.2 ) $ 293.7 $ 572.5 $ 6,585.4 $ (18.4 ) $ (3,039.5 ) $ 4,393.7 Number of Shares Amounts Common Stock Treasury Stock Common Stock Additional Paid-In Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Treasury Stock Total Stockholders' Equity January 1, 2026 293.7 (57.2 ) $ 293.7 $ 625.1 $ 6,768.2 $ (19.9 ) $ (3,664.9 ) $ 4,002.2 Net income 0.0 0.0 0.0 0.0 216.3 0.0 0.0 216.3 Other comprehensive income 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.3 Cash dividends 0.0 0.0 0.0 0.0 (72.9 ) 0.0 0.0 (72.9 ) Stock based compensation expense and stock option plan transactions 0.0 0.4 0.0 29.0 (0.1 ) 0.0 8.2 37.1 March 31, 2026 293.7 (56.8 ) $ 293.7 $ 654.1 $ 6,911.5 $ (16.6 ) $ (3,656.7 ) $ 4,186.0 Net income 0.0 0.0 0.0 0.0 202.8 0.0 0.0 202.8 Other comprehensive income 0.0 0.0 0.0 0.0 0.0 2.1 0.0 2.1 Cash dividends 0.0 0.0 0.0 0.0 (72.9 ) 0.0 0.0 (72.9 ) Stock based compensation expense and stock option plan transactions 0.0 0.2 0.0 22.8 (1.1 ) 0.0 8.1 29.8 June 30, 2026 293.7 (56.6 ) $ 293.7 $ 676.9 $ 7,040.3 $ (14.5 ) $ (3,648.6 ) $ 4,347.8 See Notes to Condensed Consolidated Financial Statements (Unaudited). 7 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (In millions, except per share data) 1.Basis of Presentation These condensed consolidated financial statements have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations and cash flows for all periods presented have been made. Results of operations for interim periods may not be representative of results expected for the full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”). The Company incurred research and development expenses in the second quarter of 2026 and 2025 of $33.9 and $35.8, respectively. The Company incurred research and development expenses in the first six months of 2026 and 2025 of $65.5 and $68.6, respectively. These expenses are included in selling, general and administrative (“SG&A”) expenses. 2.New Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03") and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with prospective or retrospective application permitted. The Company is currently evaluating the impact of adoption on the Company’s related disclosures. There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows. 3.Inventories Inventories consist of the following: June 30, December 31, 2026 2025 Raw materials and supplies $ 130.3 $ 143.7 Work in process 22.5 35.0 Finished goods 449.1 356.1 Total $ 601.9 $ 534.8 8 4.Property, Plant and Equipment, Net (“PP&E”) PP&E consists of the following: June 30, December 31, 2026 2025 Land $ 29.7 $ 16.0 Buildings and improvements 355.2 367.5 Machinery and equipment 914.7 911.1 Software 140.2 138.9 Office equipment and other assets 132.7 131.6 Construction in progress 166.9 131.9 Gross PP&E 1,739.4 1,697.0 Less accumulated depreciation 912.9 874.2 Net PP&E $ 826.5 $ 822.8 Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Depreciation expense on PP&E $ 22.0 $ 22.5 $ 43.6 $ 45.1 5.Earnings Per Share (“EPS”) Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the Company's stock-based compensation plans. The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Weighted average common shares outstanding - basic 236.7 244.7 236.6 245.2 Dilutive effect of stock awards 1.5 1.7 1.6 2.0 Weighted average common shares outstanding - diluted 238.2 246.4 238.2 247.2 Antidilutive stock awards outstanding 3.1 2.1 3.1 2.1 6.Stock Based Compensation Plans The Company's Long-Term Incentive Program (“LTIP”) provides employees with an award of stock options and grants of restricted stock units (“RSUs”), and grants of performance share units ("PSUs"). Awards are granted in the first quarter of each year. The Company recognizes the grant-date fair value for each of these awards, less estimated forfeitures, as compensation expense ratably over the vesting period. For employees and directors that meet retirement eligibility requirements, the expense related to share-based compensation is recognized on the date of grant as there is no future service period required for the awards to vest. 9 Stock Options The following table provides a summary of option activity: Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Price Term Intrinsic Options (per share) (in Years) Value Outstanding at December 31, 2025 8.8 $ 81.83 Granted 0.9 103.52 Exercised (0.4 ) 62.08 Outstanding at June 30, 2026 9.3 $ 84.63 5.7 $ 135.7 Exercisable at June 30, 2026 6.4 $ 75.83 4.4 $ 135.2 The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Intrinsic Value of Stock Options Exercised $ 6.8 $ 4.4 $ 16.4 $ 20.7 Stock Compensation Expense Related to Stock Option Awards $ 4.2 $ 4.9 $ 13.4 $ 18.0 Issued Stock Options 0.0 0.0 0.9 1.0 Weighted Average Fair Value of Stock Options issued (per share) $ 0.0 $ 0.0 $ 28.71 $ 33.05 Fair Value of Stock Options Issued $ 0.0 $ 0.0 $ 24.9 $ 34.2 The following table provides a summary of the assumptions used in the valuation of issued stock options: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Risk-free interest rate N/A N/A 3.8% 4.2% Expected life in years N/A N/A 6.7 7.0 Expected volatility N/A N/A 22.5% 22.6% Dividend yield N/A N/A 1.2% 1.1% Restricted Stock Units The annual RSU grants vest in one-third increments on each of the first, second and third anniversaries of the grant date, subject to the recipient’s continued employment with the Company from the grant date through the applicable vesting date, and are settled with shares of the Company’s Common Stock within 60 days following the applicable vesting date. 10 The following table provides a summary of RSU activity: Weighted Average Grant Date Fair Value Shares (per award) Outstanding at December 31, 2025 0.3 $ 100.40 Granted 0.2 94.47 Vested (0.2 ) 96.61 Outstanding at June 30, 2026 0.3 $ 98.53 In connection with the Touchland acquisition, Touchland’s founder was granted rights to receive shares of our common stock valued at $50.0, with 50% of such shares vesting at each of the first and second year anniversaries of the closing. The value of common stock received by Touchland's founder will be recognized as a compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. The restricted stock expense associated with the Touchland acquisition for the three and six months ended June 30, 2026 was $6.3 and $12.6, respectively, and is included in the non-cash compensation expense caption in the Condensed Consolidated Statement of Cash Flows. Refer to Note 10-Acquisitions for additional details. Performance Stock Units Beginning in 2026, the Company expanded the annual PSU grant to a greater number of employees. The annual PSU grants are issued in two equal tranches. Each tranche has a different performance metric and grant date fair value. The performance metric for one tranche is based on the Company’s total shareholder return (“TSR”) relative to a Company-selected peer group and is valued using a Monte Carlo model. The performance metric for the second tranche is the Company's three-year cumulative cash flow from operations target and is valued using the Company's grant date closing stock value. The PSUs vest on the later of (i) the third anniversary of the grant date and (ii) the date on which the Compensation & Human Capital Committee of the Company's Board of Directors (the "Board") certifies the achievement of the applicable performance goals, in each case, subject to the recipient’s continued employment with the Company from the grant date through the applicable vesting date. The number of shares that may be issued ranges from 0% to 200% based on relative TSR and cumulative cash flow from operations during the three-year performance period. In January 2026, the Company granted a 2030 long-term strategy grant of PSUs (the "Strategy Grant") to Company employees at the director level and above, including the Company's executive officers. The PSUs awarded pursuant to the Strategy Grant will cliff vest following a four-year performance period, subject to the recipients remaining continuously employed for the full four-year performance period and the satisfaction of the performance conditions. The PSU awards are tied to three equally weighted core long-term growth drivers: (1) the Company’s net sales compound annual growth rate (“CAGR”) of the Arm & Hammer brand, (2) the net sales CAGR derived from sources outside of the United States and (3) the net sales CAGR derived from oral care products, including TheraBreath. The number of shares that may be issued ranges from 0% to 200% based on the performance of the long-term growth drivers over the four-year performance period. The following table provides a summary of PSU activity: Weighted Average Grant Date Fair Value Shares (per award) Outstanding at December 31, 2025 0.1 $ 106.52 Granted 0.6 95.01 Outstanding at June 30, 2026 0.7 $ 96.68 Employee Stock Purchase Plan The Company’s Employee Stock Purchase Plan (“ESPP”) was adopted by the Board in February 2023 and became effective in April 2023 upon approval by the Company’s stockholders, and was most recently amended and restated effective April 4, 2026. There are 750,000 shares of Common Stock reserved for issuance under the ESPP. The ESPP, which is intended to be an “employee stock 11 purchase plan” under Section 423 of the Internal Revenue Code, permits eligible employees to purchase Common Stock through after-tax payroll deductions. Currently, the purchase price under the ESPP is 85% of the fair market value of our Common Stock on the last trading day of the applicable quarterly purchase period. The maximum value of Common Stock that an eligible employee may purchase each calendar year is the lesser of 10% of an eligible employee’s annual pay and $25,000. There are four purchase periods in each calendar year under the ESPP, which begin on the first business day of each calendar quarter and end on the last business day of each calendar quarter. The first purchase period commenced in January 2025. There are 706,549 shares of Common Stock remaining as of June 30, 2026 that are reserved for issuance under the ESPP. As of December 31, 2025, there were 660,582 shares of Common Stock reserved for issuance under the ESPP. 7.Share Repurchases On October 28, 2021, the Board authorized the Company’s share repurchase program, under which the Company may repurchase up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program. The 2021 Share Repurchase Program did not modify the Company’s evergreen share repurchase program, authorized by the Board on January 29, 2014, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under its incentive plans. As of June 30, 2026, there remains $228.9 of share repurchase availability under the 2021 Share Repurchase Program. 8.Fair Value Measurements The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at June 30, 2026 and December 31, 2025: June 30, 2026 December 31, 2025 Input Carrying Fair Carrying Fair Level Amount Value Amount Value Financial Assets: Cash equivalents Level 1 $ 57.3 $ 57.3 $ 217.5 $ 217.5 Financial Liabilities: Short-term borrowings Level 2 49.9 49.9 0.0 0.0 3.15% Senior notes due August 1, 2027 Level 2 425.0 419.3 424.9 420.1 2.3% Senior notes due December 15, 2031 Level 2 399.5 353.2 399.5 355.4 5.6% Senior notes due November 15, 2032 Level 2 499.4 521.9 499.3 532.3 3.95% Senior notes due August 1, 2047 Level 2 397.9 314.9 397.9 318.4 5.00% Senior notes due June 15, 2052 Level 2 499.9 452.2 499.9 457.3 The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the six months ended June 30, 2026 and 2025. Refer to Note 2 in the Form 10-K for a description of the methods and assumptions used to estimate the fair value of each class of financial instruments reflected in the Condensed Consolidated Balance Sheets. The carrying amounts of Accounts Receivable, Accounts Payable, and Accrued Expenses and Other Liabilities, approximated estimated fair values as of June 30, 2026 and December 31, 2025. 12 9.Derivative Instruments and Risk Management Changes in interest rates, foreign exchange rates, the price of the Company’s Common Stock and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign exchange forward contracts. The Company does not use derivatives for trading or speculative purposes. Refer to Note 3 in the Form 10-K for a discussion of each of the Company’s derivative instruments in effect as of December 31, 2025. The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table: Notional Notional Amount Amount June 30, 2026 December 31, 2025 Derivatives designated as hedging instruments Foreign exchange contracts $ 376.9 $ 438.2 Diesel fuel contracts 2.3 gallons 4.5 gallons Commodities contracts 33.4 pounds 43.6 pounds Net Investment hedge(1) $ 0.0 $ 25.0 Derivatives not designated as hedging instruments Foreign exchange contracts $ 6.7 $ 2.4 Equity derivatives $ 12.3 $ 12.0 (1) The Net Investment hedge matured during the second quarter of 2026 and resulted in a gain of $2.4 recorded in Accumulated Other Comprehensive Income. The fair values and amount of gain (loss) recognized in income and Other Comprehensive Income associated with the derivative instruments disclosed above did not have a material impact on the Company’s condensed consolidated financial statements during the three and six months ended June 30, 2026. 10.Acquisitions On May 28, 2026, the Company completed the acquisition of the Miss Mouth's Messy Eater® brand (“Miss Mouth's”). The Company paid $300.0 cash at closing and deferred payment of $25.0 of the purchase price with $15.0 expected to be paid later in 2026 related to required post-closing activities of the Seller. The remaining amount relates to certain indemnity obligations with, $4.0 payable in the second quarter of 2029, and $6.0 payable in the second quarter of 2031. The Miss Mouth's acquisition was financed with cash on hand and commercial paper borrowings and is managed in the Consumer Domestic segment. Miss Mouth's annual net sales for the year ended December 31, 2025 were approximately $80.0. The preliminary fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 0.5 Inventory 3.2 Other current assets 0.9 Trade name 300.0 Goodwill 20.5 Accounts payable, accrued expenses and other liabilities (0.1) Business acquisition liabilities - short-term (15.0) Business acquisition liabilities - long-term (10.0) Cash purchase price (net of cash acquired) $ 300.0 The trade name intangible asset was valued using a discounted cash flow model and has a useful life of 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and trade name intangible asset associated with the Miss Mouth's acquisition are deductible for U.S. tax purposes. On July 16, 2025, the Company completed the acquisition of Touchland Holding Corp ("Touchland"), the developer of TOUCHLAND® hand sanitizer products. The Company paid $656.0, net of cash acquired, at closing and entered into an agreement to pay an additional amount based on 2025 net sales thresholds which resulted in a cash payment of $158.7 in April 2026. In addition, the Company granted rights to Touchland’s founder to receive shares of our Common Stock valued at $50.0, with 50% of such shares vesting at each of the first- and -second-year anniversaries of the closing. The value of Common Stock received by Touchland's 13 founder will be recognized as compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. A payment of $5.0 of the purchase price was deferred related to certain indemnification obligations provided by Touchland’s equity holders, which amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing. The Touchland acquisition was financed with cash on hand and is managed in the Consumer Domestic and Consumer International segments. Touchland’s annual net sales for the year ended December 31, 2024 were approximately $115.0 million. The preliminary fair values of the net assets as of the acquisition date are set forth as follows: Accounts receivable $ 9.3 Inventory 25.8 Other current assets 1.3 Property, plant and equipment 5.5 Other long-term assets 2.1 Trade name 730.0 Customer relationship intangible asset 32.8 Goodwill 208.4 Accounts payable, accrued expenses and other liabilities (23.3 ) Business acquisition liabilities - short-term (141.9 ) Deferred income taxes (183.8 ) Deferred and other long-term liabilities (10.2 ) Cash purchase price at closing (net of cash acquired) $ 656.0 The trade name and customer relationship intangible assets were valued using a discounted cash flow model and have a useful life of 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Touchland acquisition are not deductible for U.S. tax purposes. 11.Divestitures and Business Exits Spinbrush Divestiture On May 1, 2025, the Company announced that it would exit the Spinbrush business which resulted in a pre-tax loss of $21.2, of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. We exited this business by the end of 2025. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025. Flawless Business Exit On May 1, 2025, the Company announced that it would exit the Flawless business which resulted in a pre-tax loss of $17.6, of which $6.0 was recorded in Cost of Sales and $11.6 was recorded in SG&A expenses. We exited this business by the end of 2025. Net sales of the Flawless business were $29.3 in the year ended December 31, 2025. Waterpik Showerheads Business Exit On May 1, 2025, the Company announced that it would exit the Waterpik showerheads business which resulted in a pre-tax loss of $6.5 recorded in Cost of Sales. We exited this business by the end of 2025. Net sales of the Waterpik showerheads business were $35.5 in the year ended December 31, 2025. VMS Divestiture On December 9, 2025, the Company announced a definitive agreement to sell the VitaFusion and L’il Critters (“VMS”) brands to Piping Rock Health Products, Inc. ("Piping Rock"). The agreement included the VitaFusion and L’il Critters brands, relevant trademarks and licenses, and the Company's former manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. The transaction closed on December 31, 2025 and included a short-duration transition services agreement ("TSA"). The Company has a TSA-related receivable of $0.4 as of June 30, 2026, primarily for invoices paid on behalf of Piping Rock, net of cash collected from customers. 14 In connection with the agreement, the Company derecognized PP&E of $142.9, inventory of $54.0, goodwill of $12.6 and other net assets, including leases, of $9.3 for net cash proceeds of $160.3. The VMS brands represented less than 5% of the Company’s 2025 net sales. As a result of this transaction, the Company incurred a pre-tax charge of $58.5 (post-tax of $45.6) in the fourth quarter of 2025 which was included in Other income (expense), net in the Consolidated Statements of Income. The divestiture of the Company's VMS business does not meet the criteria to be reported as discontinued operations in the consolidated financial statements as the Company's decision to divest this business does not represent a strategic shift that will have a significant impact on the Company's operations and financial results. 12.Goodwill and Other Intangibles, Net The Company has intangible assets of substantial value on its Condensed Consolidated Balance Sheet. These intangible assets are generally related to intangible assets with a useful life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset. These intangible assets are more fully explained in the following sections. Indefinite-Lived Intangible Assets The following table presents the carrying value of indefinite-lived intangible assets: June 30, December 31, 2026 2025 Gross Carrying Value Trade Names $ 1,672.2 $ 1,680.7 Sale of Spinbrush Trade Name 0.0 (7.9 ) Trade Names $ 1,672.2 $ 1,672.8 The Company’s indefinite-lived intangible impairment review is completed in the fourth quarter of each year. Fair value for indefinite-lived intangible assets was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates. On May 1, 2025, the Company announced that it would exit the Spinbrush business which resulted in a pre-tax loss of $21.2, of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. The Company’s global WATERPIK business is experiencing customer distribution losses and a decline in consumer demand, mainly due to lower consumer spending and more customers choosing value brands amid inflation. This has reduced sales, profits, and expected cash flows, eroding much of the excess fair value over carrying value for the WATERPIK trade name. As of October 1, 2025 (the date of the Company's last annual impairment test), the trade name’s carrying value was $644.7, with fair value at 117% of carrying value, down from 135% in 2024, reflecting declining sales, rising competition, business exits, and margin pressure from higher costs and tariffs. The Company's impairment analysis used an 8.0% discount rate, projected mid-single- to low double-digit revenue growth, and EBITA margins around 25%, based on current market trends and cost-lowering initiatives. Further declines in performance or adverse changes could trigger an impairment charge for the WATERPIK trade name. 15 Intangible Assets With a Useful Life The following table provides information related to the carrying value of intangible assets with a useful life: June 30, 2026 December 31, 2025 Gross Amortization Gross Carrying Accumulated Period Carrying Accumulated Impairment Amount Amortization Net (Years) Amount Amortization Charges(1) Net Amortizable intangible assets: Trade Names $ 2,366.7 $ (576.3 ) $ 1,790.4 3-20 $ 2,113.4 $ (562.1 ) $ (11.6 ) $ 1,539.7 Customer Relationships 573.2 (353.7 ) 219.5 15-20 598.5 (365.2 ) (0.7 ) 232.6 Patents/Formulas 200.7 (139.7 ) 61.0 4-20 205.6 (139.2 ) 0.0 66.4 Total $ 3,140.6 $ (1,069.7 ) $ 2,070.9 $ 2,917.5 $ (1,066.5 ) $ (12.3 ) $ 1,838.7 (1) The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses. Intangible amortization expense was $33.8 and $24.9 for the second quarter of 2026 and 2025, respectively. Intangible amortization expense amounted to $67.6 and $54.2 for the first six months of 2026 and 2025, respectively. The Company estimates that intangible amortization expense will be approximately $142.0 in 2026 and approximately $149.0 declining to $135.0 annually over the next five years. Goodwill The carrying amount of goodwill is as follows: Consumer Consumer Specialty Domestic International Products Total Balance at December 31, 2025 $ 2,255.4 $ 237.2 $ 134.9 $ 2,627.5 Touchland Acquisition adjustments 1.9 0.0 0.0 1.9 Miss Mouth's Acquisition 20.5 0.0 0.0 20.5 Balance at June 30, 2026 $ 2,277.8 $ 237.2 $ 134.9 $ 2,649.9 The Company tests goodwill for each reporting unit, which are also the Company's reportable segments. The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2026, determined that the estimated fair value substantially exceeded the carrying values of all reporting units. The determination of fair value contains numerous variables that are subject to change as business conditions change and therefore could impact fair value in the future. 13.Leases The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the Condensed Consolidated Balance Sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. Lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. 16 A summary of the Company’s lease information is as follows: June 30, December 31, Classification 2026 2025 Assets Right of use assets Other Assets $ 159.5 $ 166.0 Liabilities Current lease liabilities Accrued Expenses and Other Liabilities $ 25.2 $ 23.9 Long-term lease liabilities Deferred and Other Long-term Liabilities 146.9 153.0 Total lease liabilities $ 172.1 $ 176.9 Other information Weighted-average remaining lease term (years) 7.2 7.4 Weighted-average discount rate 5.2 % 5.2 % Three Months Three Months Six Months Six Months Ended Ended Ended Ended June 30, 2026 June 30, 2025 June 30, 2026 June 30, 2025 Statement of Income Lease cost(1) $ 8.6 $ 10.5 $ 17.4 $ 21.0 Other information Leased assets obtained in exchange for new lease liabilities net of modifications(2) $ 6.2 $ 12.2 $ 6.6 $ 18.7 Cash paid for amounts included in the measurement of lease liabilities $ 8.0 $ 10.7 $ 15.7 $ 21.2 (1)Lease expense is included in Cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first six months of 2026 and 2025 was $13.0 and $16.3, respectively, and is included in the Amortization caption in the Condensed Consolidated Statement of Cash Flows. (2)In April 2025, the Company extended the lease term at one of its leased warehouse facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $11.0 recorded in the second quarter of 2025. The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows: Operating Leases 2026 $ 16.9 2027 31.8 2028 27.7 2029 27.1 2030 26.8 2031 and thereafter 76.8 Total future minimum lease commitments 207.1 Less: Imputed interest (35.0 ) Present value of lease liabilities $ 172.1 17 14.Accounts Payable, Accrued Expenses and Other Liabilities Accounts payable, accrued expenses and other liabilities consist of the following: June 30, December 31, 2026 2025 Accounts payable $ 775.9 $ 732.4 Accrued marketing and promotion costs 194.7 221.4 Accrued wages and related benefit costs 84.3 145.7 Other accrued current liabilities 217.5 394.8 Total $ 1,272.4 $ 1,494.3 In 2015, the Company initiated a Supply Chain Finance program (“SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company for early payment. Participating suppliers negotiate their receivables sales arrangements directly with a third party. The Company is not a party to those agreements and does not have an economic interest in the suppliers' decisions to sell their receivables and has not been required to pledge any assets as security nor to provide any guarantee to third-party finance providers or intermediaries. The SCF Program may allow suppliers to obtain more favorable terms than they could secure on their own. The terms of the Company's payment obligations are not impacted by a supplier’s participation in the SCF Program. The Company's payment terms with suppliers are consistent between suppliers that elect to participate in the SCF Program and those that do not participate. As a result, the SCF Program does not have an impact to the Company's average days outstanding. As of June 30, 2026 and December 31, 2025, the obligations outstanding related to the SCF Program amounted to $111.9 and $84.7, respectively, and were recorded within Accounts Payable in the Condensed Consolidated Balance Sheets. Payments included in operating activities within the Company's Condensed Consolidated Statements of Cash Flows amounted to $216.6 and $215.6 as of June 30, 2026 and 2025, respectively. 15.Short-Term Borrowings and Long-Term Debt Short-term borrowings and long-term debt consists of the following: June 30, December 31, 2026 2025 Short-term borrowings Commercial paper issuances 49.9 0.0 Total short-term borrowings $ 49.9 $ 0.0 Long-term debt 3.15% Senior notes due August 1, 2027 $ 425.0 $ 425.0 Less: Discount 0.0 (0.1 ) 2.3% Senior notes due December 15, 2031 400.0 400.0 Less: Discount (0.5 ) (0.5 ) 5.6% Senior notes due November 15, 2032 500.0 500.0 Less: Discount (0.6 ) (0.7 ) 3.95% Senior notes due August 1, 2047 400.0 400.0 Less: Discount (2.1 ) (2.1 ) 5.00% Senior notes due June 15, 2052 500.0 500.0 Less: Discount (0.1 ) (0.1 ) Debt issuance costs, net (15.4 ) (16.4 ) Total long-term debt $ 2,206.3 $ 2,205.1 18 16.Accumulated Other Comprehensive Income (Loss) The components of changes in accumulated other comprehensive income (loss) are as follows: Accumulated Foreign Defined Other Currency Benefit Derivative Comprehensive Adjustments Plans Agreements Income (Loss) Balance at January 1, 2025 $ (53.2 ) $ 4.4 $ 17.9 $ (30.9 ) Other comprehensive income (loss) before reclassifications 23.2 0.5 (11.4 ) 12.3 Amounts reclassified to Condensed Consolidated Statement of Income (a)(b) 0.0 0.0 (3.7 ) (3.7 ) Tax benefit (expense) 0.0 (0.1 ) 4.0 3.9 Other comprehensive income (loss) 23.2 0.4 (11.1 ) 12.5 Balance at June 30, 2025 $ (30.0 ) $ 4.8 $ 6.8 $ (18.4 ) Balance at January 1, 2026 $ (31.3 ) $ 4.8 $ 6.6 $ (19.9 ) Other comprehensive income (loss) before reclassifications (4.5 ) (0.5 ) 12.4 7.4 Amounts reclassified to Condensed Consolidated Statement of Income (a) (b) 0.0 0.0 0.8 0.8 Tax benefit (expense) 0.0 0.1 (2.9 ) (2.8 ) Other comprehensive income (loss) (4.5 ) (0.4 ) 10.3 5.4 Balance at June 30, 2026 $ (35.8 ) $ 4.4 $ 16.9 $ (14.5 ) (a)Amounts reclassified to Cost of sales, SG&A expenses or interest expense. (b)The Company reclassified a loss of $0.5 and a gain of $1.4 to the condensed consolidated statements of income during the three months ended June 30, 2026 and 2025, respectively. 17. Commitments, Contingencies and Guarantees Commitments The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier. As of June 30, 2026, the Company had commitments of approximately $369.5. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements. As of June 30, 2026, the Company had various guarantees and letters of credit totaling $9.0. In connection with the December 1, 2020 acquisition of the ZICAM® brand, the Company deferred payment of $20.0 of the purchase price related to certain indemnifications provided by the seller. The Company made a cash payment of $12.9 in the first quarter of 2026 and a final payment of $2.0 in April 2026. In connection with the December 24, 2021 acquisition of the THERABREATH® brand, the Company deferred payment of $14.0 of the purchase price related to certain indemnity obligations provided by the seller. The deferred amount was payable in installments between two and four years from the closing, with the first installment payment of $2.0 paid in January 2024 and an additional $5.9 paid in the first quarter of 2025. The Company paid a final amount of $5.0 in January 2026. In connection with the October 13, 2022 acquisition of the HERO® brand, the Company deferred payment of $8.0 of the purchase price to satisfy certain indemnification obligations. The amount, to the extent not used to satisfy such indemnity obligations, is payable five years from the closing. 19 In connection with the July 16, 2025 Touchland acquisition, the business acquisition liability was contingent upon the achievement of certain 2025 net sales thresholds. The initial fair value of this business acquisition liability was $140.0, which was established in the initial purchase price allocation. During 2025, the Company increased the fair value of the business acquisition liability to $158.7 based on updated 2025 net sales. The changes in fair value resulted in $18.7 of expense recorded within the Consumer Domestic segment. In April 2026, the Company paid $158.7 to satisfy the business acquisition liability. The Company deferred a payment of $5.0 of the purchase price to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing. In connection with the May 28, 2026 Miss Mouth's acquisition, the Company deferred payment of $25.0 of the purchase price with $15.0 expected to be paid later in 2026 related to required post-closing activities of the Seller. The remaining amount relates to certain indemnity obligations with, $4.0 payable in the second quarter of 2029, and $6.0 payable in the second quarter of 2031. Legal proceedings In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows. In addition to the matters described above, from time to time in the ordinary course of its business the Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable. Any such proceedings could result in a material adverse outcome negatively impacting the Company’s business, financial condition, results of operations or cash flows. 18.Segments Segment Information The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational structure. Segment revenues are derived from the sale of the following products: Segment Products Consumer Domestic Household and personal care products Consumer International Primarily personal care products SPD Specialty products The Company also has equity in earnings of affiliates which is not reflected in a reportable segment. As of June 30, 2026, the Company held a 50% ownership interest in Armand Products Company (“Armand”). The Company’s equity in earnings of Armand totaled $2.7 and $2.8 for the three months ended June 30, 2026 and 2025 and $5.0 and $4.4 for the six months ended June 30, 2026 and 2025, respectively. Our reportable segments comprise the structure used by our Chief Executive Officer, who has been determined to be the Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. The CODM considers Operating Income for evaluating performance of each segment and making decisions about allocating capital and other resources to each segment. Asset information and capital expenditures are not regularly provided to the CODM. The following tables present financial information relating to the Company’s segments for the three months ended and six months ended June 30, 2026 and 2025. In 2025, we exited the VMS, Flawless, Spinbrush and Waterpik showerhead businesses. 20 Three Months Ended June 30, 2026 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 1,155.8 $ 297.5 $ 76.7 - $ 1,530.0 Cost of sales 615.0 156.3 47.7 17.1 836.1 Gross Profit 540.8 141.2 29.0 (17.1 ) 693.9 Marketing expenses 120.9 43.8 0.6 - 165.3 Research and Development(2) 29.9 3.1 0.9 - 33.9 Selling, general and administrative expenses 166.6 52.7 16.1 (17.1 ) 218.3 Income from Operations 223.4 41.6 11.4 - 276.4 Three Months Ended June 30, 2025 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 1,154.1 $ 277.6 $ 74.6 - $ 1,506.3 Cost of sales(3) 640.4 156.4 46.3 16.2 859.3 Gross Profit 513.7 121.2 28.3 (16.2 ) 647.0 Marketing expenses 118.0 38.3 0.8 - 157.1 Research and Development(2) 31.8 3.2 0.8 - 35.8 Selling, general and administrative expenses(4) 146.5 47.3 14.8 (16.2 ) 192.4 Income from Operations 217.4 32.4 11.9 - 261.7 Six Months Ended June 30, 2026 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 2,273.5 $ 571.4 $ 154.4 - $ 2,999.3 Cost of sales 1,193.2 299.5 96.3 35.0 1,624.0 Gross Profit 1,080.3 271.9 58.1 (35.0 ) 1,375.3 Marketing expenses 225.1 78.4 1.2 - 304.7 Research and Development(2) 57.7 6.1 1.7 - 65.5 Selling, general and administrative expenses 333.9 105.9 32.9 (35.0 ) 437.7 Income from Operations 463.6 81.5 22.3 - 567.4 Six Months Ended June 30, 2025 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 2,283.9 $ 539.5 $ 150.0 - $ 2,973.4 Cost of sales(3) 1,237.8 303.7 92.7 32.6 1,666.8 Gross Profit 1,046.1 235.8 57.3 (32.6 ) 1,306.6 Marketing expenses 225.7 66.3 1.7 - 293.7 Research and Development(2) 61.0 6.2 1.4 - 68.6 Selling, general and administrative expenses(4) 297.2 93.2 29.5 (32.6 ) 387.3 Income from Operations 462.2 70.1 24.7 - 557.0 21 (1)Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in SG&A expenses to determine operating segment income before income taxes. (2)All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment. (3)In the second quarter and first six months of 2025, the results include $30.4 of non-cash charges related to impairments of fixed assets, as well as inventory reserves primarily recorded in Consumer Domestic as a result of announcing that we were exiting the Flawless, Spinbrush and Waterpik showerhead businesses. (4)In the second quarter and first six months of 2025, the results include $20.6 of non-cash charges related to impairments of intangible assets, primarily recorded in Consumer Domestic as a result of announcing that we were exiting the Flawless, Spinbrush and Waterpik showerhead businesses. Other segment expenses for the three months ended and six months ended June 30, 2026 and 2025 include the following: Consumer Domestic Consumer International SPD Total Consolidated Depreciation & Amortization Second Quarter 2026 $ 55.9 $ 6.4 $ 2.0 $ 64.3 Second Quarter 2025 47.2 6.5 2.9 56.6 First Six Months of 2026 $ 109.8 $ 12.5 $ 4.9 $ 127.2 First Six Months of 2025 98.5 13.2 5.8 117.5 22 Product line revenues from external customers are as follows. In 2025, we exited the VMS, Flawless, Spinbrush and Waterpik showerhead businesses. Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2026 2025 2026 2025 Household Products $ 662.0 $ 650.0 $ 1,303.6 $ 1,264.9 Personal Care Products 493.8 504.1 969.9 1,019.0 Total Consumer Domestic 1,155.8 1,154.1 2,273.5 2,283.9 Total Consumer International 297.5 277.6 571.4 539.5 Total SPD 76.7 74.6 154.4 150.0 Total Consolidated Net Sales $ 1,530.0 $ 1,506.3 $ 2,999.3 $ 2,973.4 Household Products include laundry, deodorizing and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin and hair care products, and cold and remedy products. 23 CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES (In millions, except per share data)